BOG Practitioner of Excellence Award

About the BOG Practitioner Excellence Award


The Board of Governors (BOG) Practitioner Excellence Award recognizes the prototypical clinical otolaryngologist one wishes to emulate. BOG Representatives nominate individuals who, within the past 10 years, have practiced medicine in an exemplary manner and are sought out by other physicians because of their personal and effective care. The nominee should have, in addition to his or her clinical skills, one or more of the following attributes:

  • Civic leadership
  • Charitable activity
  • Leadership involvement with state, local or national medical organizations
  • Community education
  • Local civic and/or community activities
  • Academy member in good standing

BOG Practitioner of Excellence Award


This year’s AAO-HNS BOG Practitioner of Excellence awardee is J. Pablo Stolovitzky, MD. He completed his residency at Emory University, where he now serves as an adjunct associate professor in the Department of Otolaryngology. His leadership within the Academy has been exemplary, having held key roles such as Chair of the Board of Governors, Director for Private Practice on the Board of Directors, and International Coordinator.

During his term as International Coordinator, he had a profound influence in enlarging the Academy’s international footprint leading to increased membership and expanded global partnerships. His vision and work toward a more collaborative global otolaryngology community have resulted in expanded education opportunities with the International Corresponding Societies through joint meetings and the creation of the Global Grand Rounds, as well as for individuals with the International Visiting Scholars program and the AAO-HNSF journals.

A distinguished figure in his field, Dr. Stolovitzky has been recognized with numerous prestigious awards. He was inducted into the 2022 AAO-HNS Hall of Distinction as a “Living Legend” and has received the Excellence in Teaching Award and Lifetime Achievement Award from the Georgia Society of Otolaryngology. His accolades also include the AAO-HNS Distinguished Honor Award and the Board of Governors Chair Award. Dr. Stolovitzky also serves as the Secretary General of the Pan-American Association of Otolaryngology-HNS, where he is set to assume the presidency in 2026.

A highly sought-after speaker, Dr. Stolovitzky lectures nationally and internationally on nasal and sinus disorders. He is a founding member of Ear, Nose and Throat of Georgia and CEO of the twenty-otolaryngologist group practice. His recent research focuses on radiofrequency ablation of the posterior nasal nerve for chronic rhinitis, absorbable implants for nasal valve collapse, and steroid-eluting stents for nasal polyps. Dr. Stolovitzky’s contributions have significantly advanced both clinical care and global education in otolaryngology.

Previous Recipients:


 

2024: Michael T. Teixido, MD

2023: David R. Edelstein, MD

2022: G. Lee Bryant, Jr., MD

2021: Richard V. Smith, MD

2020: Kathleen C Y Sie, MD

2019: Mark S. Persky, MD

2018: Mark E. Zafereo, Jr., MD

2017: Wendy B. Stern, MD

2016: Eiji Yanagisawa, MD

2015: Robert J. Stachler, MD

2014: Joseph A. Brennan, MD

2013: Michael Setzen, MD

2012: No award given

2011: Marcy Bothwell, MD

2010: Sanjay K. Gupta, MD

2009: James L. Netterville, MD

2008: No award given

2007: No award given

2006: No award given

2005: Rick G. Love, MD

2004: Michael D. Seidman, MD

2003: Helen F. Krause, MD

2002: David W. Kennedy, MD

2001: M. Coye Shea, Jr., MD

2000: Neil O. Ward, MD

1999: Howard P. House, MD

1998: Jack L. Pulec, MD

1997: Fred D. Owens, MD

1996: John M. Conoyer, MD

No External Use or Transfer (Including AI-Based Technologies): The materials and content on this website are provided for personal, non-commercial transitory viewing only. You are prohibited from copying or transferring any materials or content accessed through this website into applications, software, bots, or websites which may allow third parties to retain or use the content, including but not limited to those using artificial intelligence-based technologies or infrastructure. Please see the Terms of Use for more information.